Co-dependency for MET and FGFR1 in basal triple-negative breast cancers
Abstract Triple-negative breast cancer (TNBC) is a heterogeneous disease that lacks both effective patient stratification strategies and therapeutic targets. Whilst elevated levels of the MET receptor tyrosine kinase are associated with TNBCs and predict poor clinical outcome, the functional role of...
Guardado en:
Autores principales: | Vanessa Y. C. Sung, Jennifer F. Knight, Radia M. Johnson, Yaakov E. Stern, Sadiq M. Saleh, Paul Savage, Anie Monast, Dongmei Zuo, Stéphanie Duhamel, Morag Park |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/895f8cc93c03496b8b2c201f974c2d24 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells.
por: Rajeshwari Mehta, et al.
Publicado: (2013) -
Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
por: Wenjie Zhao, et al.
Publicado: (2021) -
Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits
por: Chiara Giacomelli, et al.
Publicado: (2021) -
OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer
por: Jonas Steenbrugge, et al.
Publicado: (2021) -
Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner J, et al.
Publicado: (2015)